1249247

Pawel Szalecki, M.D. — FEI 3030708191

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 25, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Piaseczno (Poland)

Additional Details

Clinical Investigator (CI)